Glycoforms of human prostate-specific membrane antigen (PSMA) in human cells and prostate tissue

被引:3
|
作者
Yuan, Wei [1 ,2 ]
Liu, Baoqin [1 ,5 ]
Sanda, Miloslav [1 ,2 ]
Wei, Renhuizi [1 ,2 ]
Benicky, Julius [1 ,2 ]
Novakova, Zora [3 ]
Barinka, Cyril [3 ]
Goldman, Radoslav [1 ,2 ,4 ]
机构
[1] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA
[2] Georgetown Univ, Med Ctr, Clin & Translat Glycosci Res Ctr, Washington, DC 20007 USA
[3] Czech Acad Sci, BIOCEV, Lab Struct Biol, Inst Biotechnol, Vestec, Czech Republic
[4] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC USA
[5] China Med Univ, Dept Biochem & Mol Biol, Shenyang 110122, Peoples R China
来源
PROSTATE | 2022年 / 82卷 / 01期
基金
美国国家卫生研究院;
关键词
folate hydrolase; glutamate carboxypeptidase II; NAALADase I; N-glycosylation; PSMA; site-specific glycoform; GLUTAMATE-CARBOXYPEPTIDASE-II; N-GLYCOSYLATION; CANCER; EXPRESSION; THERAPY; DIAGNOSIS; RADIOTRACERS; LIGANDS; LESSONS; TARGET;
D O I
10.1002/pros.24254
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction N-glycosylation is a ubiquitous and variable posttranslational modification that regulates physiological functions of secretory and membrane-associated proteins and the dysregulation of glycosylation pathways is often associated with cancer growth and metastasis. Prostate-specific membrane antigen (PSMA) is an established biomarker for prostate cancer imaging and therapy. Methods Mass spectrometry was used to analyze the distribution of the site-specific glycoforms of PSMA in insect, human embryonic kidney, and prostate cancer cells, and in prostate tissue upon immunoaffinity enrichment. Results While recombinant PSMA expressed in insect cells was decorated mainly by paucimannose and high mannose glycans, complex, hybrid, and high mannose glycans were detected in samples from human cells and tissue. We noted an interesting spatial distribution of the glycoforms on the PSMA surface-high mannose glycans were the dominant glycoforms at the N459, N476, and N638 sequons facing the plasma membrane, while the N121, N195, and N336 sites, located at the exposed apical PSMA domain, carried primarily complex glycans. The presence of high mannose glycoforms at the former sequons likely results from the limited access of enzymes of the glycosynthetic pathway required for the synthesis of the complex structures. In line with the limited accessibility of membrane-proximal sites, no glycosylation was observed at the N51 site positioned closest to the membrane. Conclusions Our study presents initial descriptive analysis of the glycoforms of PSMA observed in cell lines and in prostate tissue. It will hopefully stimulate further research into PSMA glycoforms in the context of tumor staging, noninvasive detection of prostate tumors, and the impact of glycoforms on physicochemical and enzymatic characteristics of PSMA in a tissue-specific manner.
引用
收藏
页码:132 / 144
页数:13
相关论文
共 50 条
  • [1] Prostate-specific membrane antigen (PSMA) glycoforms in prostate cancer patients seminal plasma
    Mackay, Stephen
    Oduor, Ian O.
    Burch, Tanya C.
    Troyer, Dean A.
    Semmes, Oliver J.
    Nyalwidhe, Julius O.
    PROSTATE, 2024, 84 (05): : 479 - 490
  • [2] Prostate specific membrane antigen (PSMA) glycoforms and prostate cancer progression
    Mackay, Stephen
    Oduor, Ian O.
    Burch, Tanya
    Troyer, Dean A.
    Semmes, Oliver J.
    Nyalwidhe, Julius O.
    CANCER RESEARCH, 2024, 84 (06)
  • [3] Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer
    Feneley, MR
    Jan, H
    Granowska, M
    Mather, SJ
    Ellison, D
    Glass, J
    Coptcoat, M
    Kirby, RS
    Ogden, C
    Oliver, RTD
    Badenoch, DF
    Chinegwundoh, FI
    Nargund, VH
    Paris, AMI
    Britton, KE
    PROSTATE CANCER AND PROSTATIC DISEASES, 2000, 3 (01) : 47 - 52
  • [4] Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA)
    Barinka, Cyril
    Ptacek, Jakub
    Richter, Antonia
    Novakova, Zora
    Morath, Volker
    Skerra, Arne
    PROTEIN ENGINEERING DESIGN & SELECTION, 2016, 29 (03): : 105 - 115
  • [5] Imaging with prostate-specific membrane antigen (PSMA) in prostate cancer
    MR Feneley
    H Jan
    M Granowska
    SJ Mather
    D Ellison
    J Glass
    M Coptcoat
    RS Kirby
    C Ogden
    RTD Oliver
    DF Badenoch
    FI Chinegwundoh
    VH Nargund
    AMI Paris
    KE Britton
    Prostate Cancer and Prostatic Diseases, 2000, 3 : 47 - 52
  • [6] Pharmacological upregulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells
    Kranzbuhler, Benedikt
    Salemi, Souzan
    Umbricht, Christoph A.
    Mueller, Cristina
    Burger, Irene A.
    Sulser, Tullio
    Eberli, Daniel
    PROSTATE, 2018, 78 (10): : 758 - 765
  • [7] Prostate-specific membrane antigen (PSMA) enzyme activity is elevated in prostate cancer cells
    Lapidus, RG
    Tiffany, CW
    Isaacs, JT
    Slusher, BS
    PROSTATE, 2000, 45 (04): : 350 - 354
  • [8] Prostate-Specific Membrane Antigen (PSMA) PET: A Counterpart to Prostate MRI
    Chen, Christine
    Margolis, Daniel
    SEMINARS IN ROENTGENOLOGY, 2021, 56 (04) : 376 - 383
  • [9] PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) EXPRESSION AND PROSTATE CANCER SURVIVAL
    Kasperzyk, Julie
    Finn, Stephen
    Hendrickson, Whitney
    Flavin, Richard
    Fiorentino, Michelangelo
    Giovannucci, Edward
    Stampfer, Meir
    Loda, Massimo
    Mucci, Lorelei
    ANTICANCER RESEARCH, 2010, 30 (04) : 1535 - 1536
  • [10] The clinical role of prostate-specific membrane antigen (PSMA)
    Chang, SS
    Heston, WDW
    UROLOGIC ONCOLOGY, 2002, 7 (01): : 7 - 12